Latest Posts

Sep 28, 2016
TAGS: Regulatory
A New Regulatory Regime For E-Cigarettes? Health Canada Announces Plans to Introduce Vaping Legislation

Yesterday, the federal government announced that it would be tabling legislation with respect to vaping products. Health Canada’s announcement in this regard can be found here.

Read Full Article
The Growth of the Cannabis Industry

Over the past decade, cannabis distribution in North America has evolved from a criminal offense to – well, still a criminal offense – but also a billion dollar legal industry. The lines are often blurred as the cannabis industry undergoes a major regulatory and legal overhaul. As an emerging industry, we have seen, and will continue to see, an increasing number of opportunities for the development and growth of cannabis companies in both Canada and the United States. The development of cannabis in the areas of life sciences and medicine has been accompanied by an expansion of the recreational market.

Read Full Article
Sep 7, 2016
TAGS: Regulatory
Changes Could Be Coming in Canada’s Regulation of Self-Care Products: Your Chance to Weigh In!

Health Canada is undertaking a public consultation on its regulation of self-care products (non-prescription drugs, natural health products and cosmetics). This is part of a larger consultation on the Framework for Consumer Health Products, started in 2014.

Read Full Article
A Case that Could Determine the Future of Health Care in Canada

On September 6, 2016, the British Columbia Supreme Court began hearing a case (“Cambie”) that could have far-reaching effects on the face of health care in Canada.

Read Full Article
Amendment to PMPRB Compendium of Policies, Guidelines and Procedures Takes Effect

On September 1, 2016, the Patented Medicine Prices Review Board (the “PMPRB” or the “Board”), Canada’s independent quasi-judicial patented drug price watchdog, implemented an amendment (the “Amendment”) to section C.11 “Review of Prices of New Patented Drug Products at Introduction” of the Compendium of Policies, Guidelines and Procedures (the “Guidelines”)1. The Amendment brings an incremental but important change to the Guidelines, of which patentees in the pharmaceutical, biotechnology, and healthcare industries should be aware.

Read Full Article
Regulating Risk: Keeping You Up-To-Date on Product Regulation - September 2016

Here’s a look at what’s new with product regulation and oversight in Canada.

Read Full Article
The Ongoing Evolution of Canada’s Regulation of Marijuana

In the ongoing evolution of Canada’s marijuana laws, this summer, Health Canada implemented the new Access to Cannabis for Medical Purposes Regulations (“ACMPR”).  The ACMPR came into force on August 24, 2016 (replacing the old Marihuana for Medical Purposes Regulations) and provide increased access for Canadians who have been authorized by their healthcare practitioners to use cannabis for medical purposes.

Read Full Article
An Opportunity to Reshape Patented Medicines Regulation in Canada

The Patented Medicine Prices Review Board (the “PMPRB” or the “Board”) is currently canvassing stakeholder input on its Discussion Paper1 released on June 24, 2016, as part of an initiative to reform and modernize its regulatory framework.  

Read Full Article
Regulating Risk: Keeping You Up-To-Date on Product Regulation - May 2016

Here’s a look at what’s new with the Canada Consumer Product Safety Act and regulations to the Food and Drugs Act and Controlled Drugs and Substances Act.

Read Full Article
Prev 1 2 3